Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Chs (CHSCL) Other Accumulated Expenses (2019 - 2025)

Historic Other Accumulated Expenses for Chs (CHSCL) over the last 7 years, with Q3 2025 value amounting to $626.0 million.

  • Chs' Other Accumulated Expenses fell 5092.29% to $626.0 million in Q3 2025 from the same period last year, while for Aug 2025 it was $626.0 million, marking a year-over-year decrease of 5092.29%. This contributed to the annual value of $626.0 million for FY2025, which is 5092.29% down from last year.
  • As of Q3 2025, Chs' Other Accumulated Expenses stood at $626.0 million, which was down 5092.29% from $1.3 billion recorded in Q3 2024.
  • Chs' Other Accumulated Expenses' 5-year high stood at $2.2 billion during Q3 2022, with a 5-year trough of $626.0 million in Q3 2025.
  • In the last 5 years, Chs' Other Accumulated Expenses had a median value of $1.3 billion in 2021 and averaged $1.4 billion.
  • In the last 5 years, Chs' Other Accumulated Expenses surged by 6874.14% in 2022 and then tumbled by 5092.29% in 2025.
  • Quarter analysis of 5 years shows Chs' Other Accumulated Expenses stood at $1.3 billion in 2021, then skyrocketed by 68.74% to $2.2 billion in 2022, then decreased by 25.7% to $1.6 billion in 2023, then dropped by 22.22% to $1.3 billion in 2024, then crashed by 50.92% to $626.0 million in 2025.
  • Its last three reported values are $626.0 million in Q3 2025, $1.3 billion for Q3 2024, and $1.6 billion during Q3 2023.